Craig Berman

Title: Craig Berman: Innovator in Cholangiocarcinoma Treatment

Introduction

Craig Berman is a notable inventor based in Mill Valley, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of cholangiocarcinoma, a rare and aggressive form of cancer. His innovative approach has the potential to improve patient outcomes and advance cancer treatment methodologies.

Latest Patents

Craig Berman holds 1 patent for his work titled "Methods of treating cholangiocarcinoma." This patent outlines methods for treating advanced or metastatic cholangiocarcinoma in patients by administering infigratinib or a pharmaceutically acceptable salt thereof. The treatment is specifically designed for patients who have experienced progression of the disease after previous therapies.

Career Highlights

Berman is currently associated with QED Therapeutics, Inc., where he continues to develop and refine treatment options for patients suffering from cholangiocarcinoma. His work is characterized by a commitment to innovation and patient care, making him a valuable asset in the medical research community.

Collaborations

Throughout his career, Craig has collaborated with esteemed colleagues, including Riccardo Panicucci and Michael Monteith. These partnerships have fostered a collaborative environment that enhances the development of effective treatment strategies.

Conclusion

Craig Berman's contributions to the treatment of cholangiocarcinoma exemplify the impact of innovative thinking in medicine. His patent and ongoing work at QED Therapeutics, Inc. highlight the importance of research and collaboration in advancing healthcare solutions.